Journal of Clinical Oncology

Reply to: Pediatric and Adolescent Considerations for the Revised ASCO Guidelines

H H. Irene Su (H. Irene Su, MD, MSCE, University of California, San Diego, San Diego, CA, Christina Lacchetti, MHSc, American Society of Clinical Oncology, Alexandria, VA, Alison Loren, MD, MSCE, University of Pennsylvania, Philadelphia, PA) C Christina Lacchetti (American Society of Clinical Oncology, Alexandria, VA) A Alison Loren (24University of Pennsylvania Medical Center, Philadelphia, United States)
View Original
APA MLA Chicago BibTeX RIS

Article Details

Volume / Issue Vol. 43, Issue 28
Published October 01, 2025
Pages 3135-3135
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins
ISSN: 0732-183X Health Sciences

Authors (3)

H

H. Irene Su

H. Irene Su, MD, MSCE, University of California, San Diego, San Diego, CA, Christina Lacchetti, MHSc, American Society of Clinical Oncology, Alexandria, VA, Alison Loren, MD, MSCE, University of Pennsylvania, Philadelphia, PA

C

Christina Lacchetti

American Society of Clinical Oncology, Alexandria, VA

A

Alison Loren

24University of Pennsylvania Medical Center, Philadelphia, United States

Related Articles from this Journal

Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer

Ismaela Anna Vascotto, Filippo Antonica et al. Aug 2026 10.1200/jco-26-00658

Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial

Samer A. Srour, Jad Chahoud et al. Aug 2026 10.1200/jco-26-00388

Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection

Risako Komata, Kenju Ando et al. Aug 2026 10.1200/jco-26-00140

Erratum: All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE)

Ghayas C. Issa, Branko Cuglievan et al. Aug 2026 10.1200/jco-26-01743

Reply to: Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer

Irbaz Bin Riaz, R. Bryan Rumble et al. Aug 2026 10.1200/jco-26-01001